Recall Register

Food, drugs, devices › Hologic Inc

Device recall: Horizon X-Ray Bone Densitometer (DXA) Models: Horizon-A, Horizon-W, Horizon-WI, Horizon-C, Horizon-CI, Horizon-A-CN, Hor

FDA enforcement event 94905 · Class II · initiated 13 Jun 2024 · status Ongoing

DeviceVoluntary: Firm initiated1 product recordNewark, DE

Hologic Inc (Newark, DE) initiated this device recall on 13 Jun 2024; FDA lists 1 product record under event 94905, classified Class II.

FDA defines Class II as a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. 87% of the 970 device enforcement events initiated in 2024 carry the same class.

Status: Ongoing. Initiation: voluntary: firm initiated. Hologic Inc has 41 enforcement events on this register, with a median of 1 product record per event.

Recall classification reflects the relative degree of health hazard. Text in quotation marks is FDA's. openFDA export dated 28 Sep 2026.

Recalling firm

Hologic Inc, Newark, DE.

Reason for recall

"Non-conformance pertains to electromagnetic compatibility requirements according to the international technical standard IEC 60601-1-2 for the safety and essential performance of medical electrical equipment, where the result from the Horizon DXA System exceeded the limit for acceptability."

Distribution

"Worldwide distribution - US Nationwide and the countries of India, Australia, Spain, Estonia, Germany, Italy, Canada, Thailand, Dominican Republic, Portugal, Islas Canarias, Andorra, Switzerland,…"

Product records

Recall numberProductQuantityClassStatusReport date
Z-2373-2024Horizon X-Ray Bone Densitometer (DXA) Models: Horizon-A, Horizon-W, Horizon-WI, Horizon-C, Horizon-CI, Horizon-A-CN, Horizon-W-CN, Horizon-WI-CN, Horizon-CI-CN2,642 units (1037 units US; 1605 units OUS)Class IIOngoing24 Jul 2024

Context

87%of 2024 device events are Class II970 events that year
1product record in this eventfirm median: 1
41events on this register for the firm

Other enforcement events for Hologic Inc

InitiatedProduct (first record)TypeClassRecords
8 Apr 2026SELENIA DIMENSIONS MAMMOGRAPHY SYSTEMS. Model Numbers: SDA-SYS-3000-2D-HTC, SDA-SYS-3000-3D, SDM-SYS-6000-2D, SDM-SYS-60DeviceClass II2
23 Mar 2026Brand Name: Genius" Review Station Product Name: Genius" Review Station Display (Barco Monitor) Model/Catalog Number: CMDeviceClass II1
18 Feb 2026Brand Name: Aptima HPV Assay Product Name: Aptima HPV Assay Model/Catalog Number: 303585 Product Description: Aptima HPVDeviceClass II1
15 Dec 2025Brevera Breast Biopsy System Disposable 9 Gauge Needle. Biopsy Instrument.DeviceClass II1
12 Dec 2025ThinPrep¿ CytoLyt¿ Solution. Buffered Cell Wash Solution.DeviceClass II1
15 Jan 2025Brand Name: Sertera Biopsy Device Product Name: Sertera Biopsy Device Model/Catalog Number: Sertera-14 Software Version:DeviceClass II1
8 Jan 2025The Rapid fFN Specimen Collection Tube (PN: 71550-001) is a component of the Rapid fFN Specimen Collection kit (PN: 7173DeviceClass II1
13 Dec 2024Panther Fusion GBS Assay REF PRD-04484 Kit containing Panther Fusion GBS Reagent Cartridge IVD.DeviceClass II1
8 Nov 2024Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay, REF: PRD-07400DeviceClass II1
10 Oct 2024BioZorb Marker. Radiographic soft tissue marker.DeviceClass I1

All 41 events for Hologic Inc

Questions and answers

Why was this device recalled?

FDA's record gives the reason for recall as: "Non-conformance pertains to electromagnetic compatibility requirements according to the international technical standard IEC 60601-1-2 for the safety and essential performance of medical electrical equipment, where the result from the Horizon DXA System exceeded the limit for acceptability."

What does Class II mean?

FDA classifies recalls by relative degree of health hazard. Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote.

Where was the product distributed?

FDA's distribution pattern field reads: "Worldwide distribution - US Nationwide and the countries of India, Australia, Spain, Estonia, Germany, Italy, Canada, Thailand, Dominican Republic, Portugal, Islas Canarias, Andorra, Switzerland,…"

Is the recall still ongoing?

FDA lists the status as Ongoing. "Terminated" means FDA has determined that all reasonable efforts to remove or correct the product have been made.

Where does this data come from?

openFDA enforcement reports (food, drug and device), CC0, export dated 28 Sep 2026. Text in quotation marks is FDA's. The FDA enforcement report linked above is authoritative.

Provenance

Source: openFDA device enforcement reports (CC0), export dated 28 Sep 2026; records grouped by FDA event number. The class shown for the event is the most severe class among its records. Errors in processing are corrected at the next build; see corrections.